Home > Financial Ratios > NATCO PHARMA
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 5.359.7111.3063.7525.37

What is the latest EV/EBIT ratio of NATCO PHARMA ?

The latest EV/EBIT ratio of NATCO PHARMA is 5.35 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar20255.35
Mar20249.71
Mar202311.30
Mar202263.75
Mar202125.37

How is EV/EBIT of NATCO PHARMA Trending?

Years EV/EBIT % Change
Mar2025 5.35
-44.90
Mar2024 9.71
-14.07
Mar2023 11.3
-82.27
Mar2022 63.75
151.28
Mar2021 25.37 -

Other Financial Ratios of NATCO PHARMA


Compare EV/EBIT ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,993.9 Cr 8% 15.7% -33.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,343.0 Cr -0.7% 7.4% -0.1% Stock Analytics
DIVIS LABORATORIES ₹171,774.0 Cr -0.1% -4.8% 3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,665.0 Cr 2.2% 6.3% 11.4% Stock Analytics
CIPLA ₹122,878.0 Cr -0.6% 1.2% NA Stock Analytics
DR REDDYS LABORATORIES ₹106,581.0 Cr 1.5% 6.4% 4.8% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

8%

15.7%

-33.9%

SENSEX

-0.5%

1.5%

6.9%


You may also like the below Video Courses